Publications

5803 Results

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803 [PMC2787689; PMID19934290]

Authors
S Ogino;JA Meyerhardt;D Niedzwiecki;D Hollis;L Saltz;RJ Mayer;P Schaefer;R Whittom;A Hantel;AB Benson;RM Goldberg;M Bertagnolli;C Fuchs
Journal / Conference
Clinical Cancer Research 15(23):7322-7329
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Cooperative group research endeavors in small-cell lung cancer: current and future directions [PMID19808190]

Authors
R Sangha;P Lara;AA Adjei;P Baas;H Choy;L Gaspar;G Goss;N Saijo;JH Schiller;EE Vokes;D Gandara
Journal / Conference
Clinical Lung Cancer 10(5):322-330
Year
2009
Research Committee(s)
Lung
PMC
n/a (review)
Study Number(s)
S0124

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer [PMID18992248]

Authors
JJ Farrell;H Elsaleh;M Garcia;R Lai;A Ammar;WF Regine;R Abrams;A Benson;J Macdonald;CE Cass;AP Dicker;JR Mackey
Journal / Conference
Gastroenterology 136(1):187-195
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Minority report: how best to analyze clinical trial data to address disparities

Authors
D Hershman;J Unger
Journal / Conference
Breast Cancer Research and Treatment 118:519-521
Year
2009
Research Committee(s)
Breast, Genitourinary, Gynecologic, Head and Neck, Leukemia, Lung, and Lymphoma
Study Number(s)
S0509, SWOG-7436, SWOG-7524, SWOG-7713/14, SWOG-7823/24/25/26, SWOG-7827, SWOG-7923, SWOG-7925, SWOG-8124/25/26, SWOG-8232, SWOG-8241, SWOG-8313 (EST 5186), SWOG-8412, SWOG-8494 (INT-0036), SWOG-8501 (INT-0051), SWOG-8516 (INT-0067), SWOG-8600, SWOG-8738, SWOG-8812, SWOG-8994 (EST-C-0690) (INT-0086), SWOG-8997 (EST-3887) (ECOG-3887), SWOG-9031, SWOG-9308

Relationship between topoisomerase 2A RNA expression and recurrence after adjuvant chemotherapy for breast cancer

Authors
J Sparano;L Goldstein;B Childs;S Shak;D Brassard;S Badve;F Baehner;R Bugarini;S Rowley;E Perez;L Shulman;S Martino;NE Davidson;G Sledge;R Gray
Journal / Conference
Clinical Cancer Research 15(24):7693-7700
Year
2009
Research Committee(s)
Breast
PMID
PMID19996222
PMC
PMC3396025
Study Number(s)
E2197

External beam irradiation and cisplatin and carmustine followed by carmustine alone for the treatment of high grade glioma: a phase 2 Southwest Oncology Group trial [PMID18521920 ]

Authors
DT Blumenthal;C Rankin;HJ Eyre;RB Livingston;AM Spence;KJ Stelzer;EJ Rushing;MS Berger;SE Rivkin;AL Cohn;SH Petersdorf
Journal / Conference
Cancer 113(3):559-565
Year
2008
Research Committee(s)
Brain
Study Number(s)
SWOG-9016

Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy [PMID18165645]

Authors
CM Moinpour;KA Hayden;JM Unger;IM Thompson Jr;MW Redman;ED Canby-Hagino;BA Higgins;JW Sullivan;D Lemmon;S Breslin;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(1):112-120
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8994 (EST-C-0690) (INT-0086)

Antiandrogen withdrawal in hormone refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426) [PMID18383517; PMC3359896]

Authors
AO Sartor;CM Tangen;MHA Hussain;MA Eisenberger;M Parab;JA Fontana;RA Chapman;GM Mills;D Raghavan;ED Crawford
Journal / Conference
Cancer 112(11):2392-2400
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9426

A phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group study 9626 [PMID18375894 ]

Authors
JW Goodwin;SJ Green;CM Moinpour;JD Bearden III;JK Giguere;CS Jiang;SM Lippman;S Martino;KS Albain
Journal / Conference
Journal of Clinical Oncology 26(10):1650-1656
Year
2008
Research Committee(s)
Breast
Study Number(s)
S9626

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of ititial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200) [PMC2276605; PMID17949799]

Authors
DS Alberts;PY Liu;SP Wilczynski;MC Clouse;AM Lopez;DP Michelin;VJ Lanzotti;M Markman
Journal / Conference
Gynecologic Oncology 108:90-94
Year
2008
Research Committee(s)
Gynecologic
Study Number(s)
S0200